Generic supplies of semaglutide from Dr Reddy’s Laboratories have hit a stumbling block, and this is having a domino effect across other companies, including Torrent Pharmaceuticals and USV

Dr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to out-of-specification batches associated with an active ingredient…

Dr. Reddy's delays semaglutide supply due to ingredient issues, impacting shares but posing no safety risks.

Dr Reddy's shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active pharmaceutical…